Ozempic and Wegovy may raise hair loss risk in some men

Data ReadoutnegativeOzempicWegovyZepboundNegative

AI Analysis

Summary

Research findings suggest GLP-1 drugs including Ozempic, Wegovy, and Zepbound may increase hair loss risk by 7% in men with genetic predisposition to male-pattern baldness, potentially reflecting a biological link beyond rapid weight loss effects.

Outcome Details

GLP-1 drugs may increase hair loss risk by 7% in men genetically susceptible to male-pattern baldness

Importance:4/10

Sentiment:

-0.60

safetyadverse_effectGLP-1hair_losspost-market

Related Companies

$NVO $LLY

Read the original article

Published by ScienceDaily Pharmaceuticals on September 13, 2026 2:18 AM

Read Original